193 related articles for article (PubMed ID: 20470666)
1. Does intracochlear brain-derived nerve growth factor improve auditory brainstem click thresholds in sensorineural hearing loss?
Meen E; Blakley B; Quddusi T
J Otolaryngol Head Neck Surg; 2010 Jun; 39(3):232-5. PubMed ID: 20470666
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived nerve growth factor in the treatment of sensorineural hearing loss.
Meen E; Blakley B; Quddusi T
Laryngoscope; 2009 Aug; 119(8):1590-3. PubMed ID: 19479743
[TBL] [Abstract][Full Text] [Related]
3. Delayed electrical stimulation and BDNF application following induced deafness in rats.
Song BN; Li YX; Han DM
Acta Otolaryngol; 2009 Feb; 129(2):142-54. PubMed ID: 18607918
[TBL] [Abstract][Full Text] [Related]
4. The effect of cochleostomy and intracochlear infusion on auditory brain stem response threshold in the guinea pig.
Carvalho GJ; Lalwani AK
Am J Otol; 1999 Jan; 20(1):87-90. PubMed ID: 9918180
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor treatment does not improve functional recovery after hair cell regeneration in the pigeon.
Radeloff A; Smolders JW
Acta Otolaryngol; 2006 May; 126(5):452-9. PubMed ID: 16698693
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss.
Vivero RJ; Joseph DE; Angeli S; He J; Chen S; Eshraghi AA; Balkany TJ; Van de Water TR
Laryngoscope; 2008 Nov; 118(11):2028-35. PubMed ID: 18818553
[TBL] [Abstract][Full Text] [Related]
7. Protective role of resveratrol against cisplatin induced ototoxicity in guinea pigs.
Yumusakhuylu AC; Yazici M; Sari M; Binnetoglu A; Kosemihal E; Akdas F; Sirvanci S; Yuksel M; Uneri C; Tutkun A
Int J Pediatr Otorhinolaryngol; 2012 Mar; 76(3):404-8. PubMed ID: 22261612
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived nerve growth factor in the cochlea - a reproducibility study.
Blakley BW; Seaman M; Alenezi A
J Otolaryngol Head Neck Surg; 2020 Jun; 49(1):37. PubMed ID: 32503640
[TBL] [Abstract][Full Text] [Related]
9. Long-term audiometric follow-up of click-evoked auditory brainstem response in hearing-impaired infants.
Schoonhoven R; Lamoré PJ; de Laat JA; Grote JJ
Audiology; 2000; 39(3):135-45. PubMed ID: 10905399
[TBL] [Abstract][Full Text] [Related]
10. Infant air and bone conduction tone burst auditory brain stem responses for classification of hearing loss and the relationship to behavioral thresholds.
Vander Werff KR; Prieve BA; Georgantas LM
Ear Hear; 2009 Jun; 30(3):350-68. PubMed ID: 19322084
[TBL] [Abstract][Full Text] [Related]
11. Chronic depolarization enhances the trophic effects of brain-derived neurotrophic factor in rescuing auditory neurons following a sensorineural hearing loss.
Shepherd RK; Coco A; Epp SB; Crook JM
J Comp Neurol; 2005 May; 486(2):145-58. PubMed ID: 15844207
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor modulates auditory function in the hearing cochlea.
Sly DJ; Hampson AJ; Minter RL; Heffer LF; Li J; Millard RE; Winata L; Niasari A; O'Leary SJ
J Assoc Res Otolaryngol; 2012 Feb; 13(1):1-16. PubMed ID: 22086147
[TBL] [Abstract][Full Text] [Related]
13. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY
Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519
[TBL] [Abstract][Full Text] [Related]
14. Comparison of auditory steady-state responses and auditory brainstem responses in audiometric assessment of adults with sensorineural hearing loss.
Lin YH; Ho HC; Wu HP
Auris Nasus Larynx; 2009 Apr; 36(2):140-5. PubMed ID: 18620826
[TBL] [Abstract][Full Text] [Related]
15. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model.
Murphy D; Daniel SJ
Otolaryngol Head Neck Surg; 2011 Sep; 145(3):452-7. PubMed ID: 21521888
[TBL] [Abstract][Full Text] [Related]
16. Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss?
Parham K
Otolaryngol Head Neck Surg; 2011 Oct; 145(4):635-40. PubMed ID: 21572077
[TBL] [Abstract][Full Text] [Related]
17. End points for cisplatin ototoxicity.
Qureshy K; Blakley B; Alsaleh S; Quddusi T; Berard S
J Otolaryngol Head Neck Surg; 2011 Feb; 40 Suppl 1():S45-8. PubMed ID: 21453661
[TBL] [Abstract][Full Text] [Related]
18. Candidate's thesis: Platelet-activating factor-induced hearing loss: mediated by nitric oxide?
Rhee CK
Laryngoscope; 2003 Dec; 113(12):2059-66. PubMed ID: 14660903
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant treatment reduces blast-induced cochlear damage and hearing loss.
Ewert DL; Lu J; Li W; Du X; Floyd R; Kopke R
Hear Res; 2012 Mar; 285(1-2):29-39. PubMed ID: 22326291
[TBL] [Abstract][Full Text] [Related]
20. Normal cochlear function in mdx and mdx(Cv3) Duchenne muscular dystrophy mouse models.
Pillers DA; Duncan NM; Dwinnell SJ; Rash SM; Kempton JB; Trune DR
Laryngoscope; 1999 Aug; 109(8):1310-2. PubMed ID: 10443839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
